NMPA Medical Device Registration Timeline
This page summarizes the official regulatory timelines for medical device registration with NMPA, based on the Provisions for Medical Device Registration and Filing (Order No. 47, revised 2024).
Technical Review Timelines (Working Days)
| Phase | Class II | Class III |
|---|---|---|
| Acceptance review (completeness check) | ~5 working days | ~5 working days |
| Administrative timeline (NMPA decision evaluation) | ~35 working days | ~35 working days |
| 1st Technical review (CMDE) | 60 working days | 90 working days |
| Supplementary notice response window | Max 1 year | Max 1 year |
| 2nd Technical review (after supplement) | 60 working days | 60 working days |
| Administrative evaluation | 20 working days | 20 working days |
| Certificate issuance | 10 working days | 10 working days |
Note: Clock stops during the period when the applicant prepares supplementary materials. The maximum response window is 1 year from receipt of the supplementary notice.
Total Estimated Timeline (End-to-End)
| Phase | Class II (Typical) | Class III (Typical) |
|---|---|---|
| Agent appointment & preparation | 1-2 months | 1-2 months |
| Product testing (in China) | 3-8 months | 6-12 months |
| Clinical evaluation/trial | 0-6 months (literature) | 6-36 months (clinical trial) |
| Dossier preparation & translation | 2-4 months | 3-6 months |
| CMDE technical review | 4-8 months | 6-18 months |
| Supplemental information cycles | 0-6 months | 2-12 months |
| Administrative review & certificate | 1-2 months | 1-3 months |
| Total estimated range | 12-24 months | 24-60 months |
Registration Renewal
Once registered, renewal (every 5 years) technical review averages approximately 1.5 months.
Key Regulations
- Provisions for Medical Device Registration and Filing (Order No. 47) — Article 92 defines technical review time limits
- Submissions via electronic Regulated Product Submission (eRPS) platform
Important Notes
- Class I devices require only filing (5 working days) and are exempt from technical review
- All imported devices are registered at national NMPA level regardless of class
- Timeline variations depend on: device complexity, clinical data requirements, quality of initial submission, and response speed to supplementary notices
Last updated: July 2026
Sources: NMPA Order No. 47 (2024 revision), European Commission NB Survey data, industry benchmarks